00:00Part of my role is feasibility, and that literally is looking at where the locations,
00:04the countries we actually go to for a clinical trial, the physicians, the types of institutions
00:09that we take. And admittedly, when we took a look at all of the different sites that we actually
00:15placed our clinical trials, we use the same ones over and over again. Even across pharma,
00:19we use the same ones over and over again. And we really needed to think about how can we expand
00:25access even from a geography standpoint. So if there are patients, we need a site there.
00:30And we were able to do that with expanding sites into the U.S. territory of Puerto Rico.
00:34We also were looking at the southeast, which tends to have less clinical trial sites than in the
00:40northeast in California, and really trying to highlight those physicians that are doing research
00:45and bringing the research to them and being a little bit more, I would say, even proactive,
00:51aggressive with making sure that they're included in our clinical trials. So geography was one way.
00:57The other part was really looking at healthcare providers who are not involved with clinical
01:02research, because about only 3% of physicians actually execute a clinical trial. So think about
01:08that. 3% of physicians. Most of the doctors that our patients are going to every day are not active
01:14on a trial. So right there is that opportunity gap. And how can we continue to not only educate
01:19healthcare providers about clinical research? We had a discussion about that earlier, about that
01:23statistic. And use them as conduits so they can also provide that education to their patients.
01:28requirements.
01:33states.
01:36So we'll see you again.
01:44.
01:45.
01:47Kind of black wins.
01:48.
01:48.
01:51We'll see you again.
01:53.
01:54.
01:55.
01:56.
01:56.
01:56.
Comments